Pevion appoints new CEO amid CHF10 million fundraising
This article was originally published in Scrip
Executive Summary
Pevion, the privately-held Swiss vaccine company, has appointed Dr Evert Kueppers CEO and has raised CHF10 million ($9.9 million) in a private financing round. Dr Kueppers succeeds Thomas Stauffer as head of the company.